Volume 19 Issue 12
Dec.  2021
Turn off MathJax
Article Contents
MU Xi-yuan, ZHANG Chen, WANG Xiao-rong. Analysis of related factors of treatment compliance in patients with schizophrenia[J]. Chinese Journal of General Practice, 2021, 19(12): 2081-2083. doi: 10.16766/j.cnki.issn.1674-4152.002242
Citation: MU Xi-yuan, ZHANG Chen, WANG Xiao-rong. Analysis of related factors of treatment compliance in patients with schizophrenia[J]. Chinese Journal of General Practice, 2021, 19(12): 2081-2083. doi: 10.16766/j.cnki.issn.1674-4152.002242

Analysis of related factors of treatment compliance in patients with schizophrenia

doi: 10.16766/j.cnki.issn.1674-4152.002242
Funds:

 81771450

  • Received Date: 2021-05-13
    Available Online: 2022-03-02
  •   Objective  To investigate and analyse the related factors of treatment compliance in patients with schizophrenia and provide reference for clinical intervention.  Methods  A total of 150 cases of convalescent schizophrenic patients who were treated in our hospital from January 2019 to December 2020 were selected, and their treatment compliance was investigated by using the Morisky medication compliance questionnaire (MMAS-8). Logistic regression analysis was used to analyse the influencing factors of treatment compliance.  Results  Amongst the 150 patients, 73 cases of complete compliance, 43 cases of partial compliance, 34 cases of non-compliance, 116 cases (77.33%) of good treatment compliance and 34 cases (22.67%) of poor treatment compliance were identified. The level of education, course of disease, treatment cost, length of hospital stay, mastery of disease knowledge, return visit, treatment emergent symptom scale (TESS) score and brief psychiatric rating scale (BPRS) score were compared between the two groups, and the difference was statistically significant (χ2=4.005, P=0.045; t=3.505, P < 0.001; t=6.179, P < 0.001; t=4.165, P < 0.001; χ2=7.273, P=0.007; χ2=4.193, P=0.041; t=12.592, P < 0.001; t=20.250, P < 0.001). Multivariate logistic regression analysis showed that the level of education, low educational level, Tess score ≥ 30 and BPRS score > 35 are the risk factors affecting treatment compliance. Hospitalization time ≥ 45 days, good mastery of disease knowledge and regular follow-up are the protective factors of treatment compliance.  Conclusion  Several factors influencing the treatment compliance of schizophrenic patients are identified. The TESS and BPRS scores are inversely proportional to treatment compliance, the lower the score, the higher the treatment compliance.

     

  • loading
  • [1]
    余波, 徐方云. 精神分裂症发病原因及与遗传关系的研究进展[J]. 南昌大学学报(医学版), 2013, 53(6): 97-100. doi: 10.3969/j.issn.1000-2294.2013.06.030
    [2]
    何镒民. 精神分裂症患者大脑结构异常的CT表现[J]. 影像研究与医学应用, 2018, 2(14): 67-69. doi: 10.3969/j.issn.2096-3807.2018.14.037
    [3]
    蒋凯, 王丹, 翟金国. 事件相关电位在精神分裂症中的应用进展[J]. 精神医学杂志, 2020, 33(1): 70-73. https://www.cnki.com.cn/Article/CJFDTOTAL-SDJB202001016.htm
    [4]
    丁兆猛, 陈振林. 阿立哌唑联合氯氮平对难治性精神分裂症患者体质量指数、低密度脂蛋白胆固醇、总胆固醇水平的影响[J]. 实用临床医药杂志, 2017, 21(19): 212. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL201719078.htm
    [5]
    唐本玲, 沈尤兰, 田雪入, 等. 利培酮联合盐酸丁螺环酮片改善精神分裂症患者康复期认知功能[J]. 神经损伤与功能重建, 2019, 14(3): 153-155. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF201903016.htm
    [6]
    石银燕, 夏泳. 团体心理治疗对首发精神分裂症患者认知功能、社会功能及疗效的影响[J]. 中华全科医学, 2018, 16(6): 957-960. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201806030.htm
    [7]
    罗晓东, 吕跃中, 贾雪珍, 等. 阿立哌唑联合丁螺环酮治疗精神分裂症的效果及安全性分析[J]. 中华全科医学, 2021, 19(1): 83-85, 123. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202101025.htm
    [8]
    吕立召, 张娟, 王娜, 等. 计算机认知矫正治疗对慢性精神分裂症患者治疗依从性、认知功能及生命质量的影响[J]. 中国社会医学杂志, 2019, 36(6): 607-610. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSY201906015.htm
    [9]
    中华医学会精神病学分会. 中国精神障碍分类与诊断标准第三版(精神障碍分类)[J]. 中华精神科杂志, 2001, 34(3): 184-188. doi: 10.3760/j:issn:1006-7884.2001.03.028
    [10]
    熊震. 以患者为中心的群体心理治疗对精神分裂症患者负性情绪和服药依从性的影响[J]. 基层医学论坛, 2018, 22(34): 4870-4871. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLT201834053.htm
    [11]
    魏玲, 甘霖, 龚飞中. 阿立哌唑对长期封闭式管理的女性精神分裂症患者社会功能及生活质量的影响[J]. 中国当代医药, 2019, 26(10): 78-81, 85. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD201910023.htm
    [12]
    吴明, 田国强, 吴景竹. 绍兴市社区精神分裂症患者治疗依从性影响因素的研究[J]. 浙江医学, 2018, 40(10): 1084-1087. doi: 10.12056/j.issn.1006-2785.2018.40.10.2017-1424
    [13]
    张红梅, 赵占胜, 孙志刚, 等. 精神分裂症恢复期复发影响因素的研究[J]. 国际精神病学杂志, 2017, 44(3): 411-413, 426. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ201703009.htm
    [14]
    吴燕筱, 孙焱, 王志忠. 中国西部某省2011-2016年社区在管精神分裂症患者死因分析[J]. 中国心理卫生杂志, 2019, 33(8): 577-582. doi: 10.3969/j.issn.1000-6729.2019.08.005
    [15]
    王超芬. 长期服用抗精神病药物对精神分裂症患者代谢的影响[J]. 临床合理用药杂志, 2020, 13(13): 48-49. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY202013025.htm
    [16]
    中华医学会精神医学分会精神分裂症协作组. 精神分裂症患者代谢综合征管理的中国专家共识[J]. 中华精神科杂志, 2020, 53(1): 3-4, 10. doi: 10.3760/cma.j.issn.1006-7884.2020.01.002
    [17]
    陈玉琴. 110名精神分裂症出院患者服药依从性的现状及影响因素分析[J]. 当代护士(下旬刊), 2019, 26(3): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-DDHZ201903007.htm
    [18]
    高镇松, 陈泽华, 徐丽缄, 等. 社区精神分裂症患者、家属和精神病防治人员对疾病认知、治疗依从性及社区服务评价的质性研究[J]. 中华行为医学与脑科学杂志, 2020, 29(3): 271-272, 276. doi: 10.3760/cma.j.cn371468-20200117-00995
    [19]
    张婷婷. 俞玮, 张洁, 等. 慢性精神分裂症患者药物依从性及其自身影响因素研究[J]. 中国药物与临床, 2019, 19(19): 3311-3313. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201919022.htm
    [20]
    石贺敏. 首发精神分裂症患者随访1年复发规律及相关因素分析[D]. 唐山: 华北理工大学, 2015.
    [21]
    闫丽琼, 冯萍, 马良. 精神分裂症患者随访1年的复发规律及因素探讨[J]. 中国健康心理学杂志, 2017, 25(5): 663-666. https://www.cnki.com.cn/Article/CJFDTOTAL-JKXL201705007.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (323) PDF downloads(11) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return